首页 › 基金 › PRIMECAP MANAGEMENT CO/CA/ › GSK

PRIMECAP MANAGEMENT CO/CA/ 对 GSK 的持仓历史

GSK PLC · 医疗保健

PRIMECAP MANAGEMENT CO/CA/ 在 Q3 2026 的 13F 申报中披露持有 GSK(GSK PLC)25,192,138 股,市值约 US$1.21B,约占其申报组合的 0.75%,在其申报持仓中市值排名第 35 位。 PRIMECAP MANAGEMENT CO/CA/ 最近 13 个申报季度中有 13 个季度披露了 GSK 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)25.19M 股
申报持仓市值$1.21B
组合权重0.75%
首次申报Q3 2023
最近变动持有
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

PRIMECAP MANAGEMENT CO/CA/ 对 GSK 的持仓演变

PRIMECAP MANAGEMENT CO/CA/ 于 Q3 2023 首次披露 GSK 持仓:12,058,770 股(约 US$437.1M)。 该持仓在 Q1 2026 达到峰值 25,204,538 股,市值约 US$1.39B。 在 13 次申报中,PRIMECAP MANAGEMENT CO/CA/ 6 次增持、2 次减持、4 次保持不变。 最近一期申报(Q3 2026)显示持股 25,192,138 股、市值约 US$1.21B。 持仓曾出现大幅变动:Q4 2024 增持约 70% (随后一个季度股价上涨 15%)。

逐季持仓明细

季度股数金额变化
Q3 2023 12.06M $437.13M 新进
Q4 2023 12.09M $448.03M 持有
Q1 2024 12.74M $546.09M 增持
Q2 2024 14.51M $558.69M 增持
Q3 2024 14.85M $607.22M 增持
Q4 2024 25.26M $854.35M 增持
Q1 2025 25.71M $995.93M 增持
Q2 2025 27.73M $1.06B 增持
Q3 2025 25.77M $1.11B 减持
Q4 2025 25.13M $1.23B 减持
Q1 2026 25.20M $1.39B 持有
Q2 2026 25.18M $1.32B 持有
Q3 2026 25.19M $1.21B 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 GSK 与 13F 数据

GSK(GSK PLC)属于医疗保健行业。我们追踪的基金中还有 19 只申报持有 GSK,申报仓位最大的包括:Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), JTC Employer Solutions Trustee Ltd (US$389.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 GSK 的基金

查看 GSK 的全部基金持有人 →

常见问题

How long has PRIMECAP MANAGEMENT CO/CA/ held GSK?

PRIMECAP MANAGEMENT CO/CA/ has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PRIMECAP MANAGEMENT CO/CA/'s current position in GSK?

As of Q3 2026, PRIMECAP MANAGEMENT CO/CA/ holds 25.19M shares of GSK (GSK PLC), valued at $1.21B, representing 0.75% of its reported portfolio and ranking #35.

Has PRIMECAP MANAGEMENT CO/CA/ been buying or selling GSK?

In the latest 13F filing (Q3 2026), PRIMECAP MANAGEMENT CO/CA/ held unchanged its position in GSK. The position peaked in Q1 2026 at 25.20M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, JTC Employer Solutions Trustee Ltd, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.